Takeda, HealthPartners & more: 3 GI company key notes

Here are three updates on gastroenterology and industry-relevant companies to note:

Takeda's ulcerative colitis drug, Entyvio was one of the key products behind a 10.5 percent increase in underlying revenue for the third quarter of 2018.

Bloomington, Minn.-based HealthPartners was one of two organizations to receive CMS' Health Equity Award.

The International Society for Diseases of the Esophagus named Kansas City-based University of Kansas Cancer Center gastroenterologist Prateek Sharma, MD, its new president.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars